INM
InMed Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · CA
$1.63
+1.61%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 8.63x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 8.30x
- Price / sales
- 0.00x
- Price / cash flow
- -0.88x
Enterprise value
- Enterprise value
- $6.7M
- EV / sales
- 0.00x
- EV / EBITDA
- -0.68x
- EV / EBIT
- -0.63x
- Market cap
- $8.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026